Pancreatic

Pancreatic Cancer Test Gets CPT Code, Preliminary Payment Determination from the CMS

The AMA issued a new Current Procedural Terminology (CPT) Proprietary Laboratory Analyses (PLA) code for the Avantect Pancreatic Cancer Test.

Pancreatic

PancreaSeq Molecular Test Outperforms Current Guidelines

The PancreaSeq molecular test accurately classifies pancreatic cysts as potentially cancerous or benign, a large, multi-center study found.

Pancreatic

New Genetic Targets Could Revolutionize Early Pancreatic Cancer Detection

Researchers from Johns Hopkins and an international team, have identified promising new targets for pancreatic cancer treatment and early diagnosis.

Blood Test May Help Doctors Catch Pancreatic Cancer Early

May 6, 2020 | Cancer, Pancreatic

Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging of pancreatic cancer.

Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer

May 4, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

The blood test followed by PET-CT imaging was 99.6% specific for cancer.

Interventional Study to Evaluate Multicancer Early Detection Test

Apr 21, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.

Cancer Detection and Liquid Biopsy

Apr 13, 2020 | Cancer, Molecular Diagnostics, Pancreatic, Specimen Collection & Handling

Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.

Study Offers Promise for Multicancer Detection from a Single Blood Draw

Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.

US Preventive Services Task Force Issues Final Recommendation on BRCA-Related Cancer Prevention

Oct 1, 2019 | Breast, Pancreatic, Prostate

Some women may benefit from risk assessment, counseling, and testing for rare genetic mutations, says USPSTF.

BRACAnalysis CDx Identifies Patients with Metastatic Pancreatic Cancer Who Benefit from Treatment with Lynparza

Sep 24, 2019 | Pancreatic

Updated guidelines from the National Comprehensive Cancer Network recommend genetic testing for all patients with pancreatic cancer.

Biodesix and Immodulon Announce Research Collaboration for Pancreatic Cancer Treatment

Sep 9, 2019 | Cancer, Pancreatic

The partnership will focus on analysis of the circulating proteome of advanced pancreatic cancer patients, using the Biodesix Diagnostic Cortex machine-learning platform.

Researchers Advance Method for Characterizing Pancreatic Cancer

Jul 30, 2019 | Cancer, Molecular Diagnostics, Pancreatic

An Okayama University study reports the utility of identifying PD-L1 status at the time of diagnosing pancreatic cancer and demonstrates that fine-needle aspiration can be useful in facilitating such diagnoses.

BRACAnalysis CDx Test Planned as Companion Diagnostic in Pancreactic Cancer

Mar 8, 2019 | Pancreatic, Research

Early results suggest the test can help expand the population of patients who can benefit from BRCA testing.

Immunovia to Develop Blood-Based Biomarker Tests for Rheumatoid Arthritis

Nov 14, 2018 | Controls, Pancreatic

In a recent study, the company’s IMMray biomarker signatures achieved accuracy greater than 90% when diagnosing CCP-negative rheumatoid arthritis patients compared to healthy controls.

Biomarker Test Accurately Detects Early-Stage Pancreatic Cancer

Sep 28, 2018 | Pancreatic

Immunovia’s serum biomarker microarray detects pancreatic cancer in the early stages of development with 96% accuracy.

Linköping University Hospital Joins Clinical Study for Early Detection of Pancreatic Cancer

Jun 21, 2018 | Pancreatic, Research

The PanFAM-1 study is designed to validate Immunovia’s IMMray PanCan-d assay, the first blood-based test for early detection of pancreatic cancer.

Spanish Hospital Joins World’s Largest Study of Risk for Familial Pancreatic Cancer

Jun 12, 2018 | Pancreatic, Research

Designed to validate Immunovia’s blood-based test for familial pancreatic cancer risk, the study will analyze more than 1,000 individuals across sites in the United States and Europe.

Ortho Clinical Diagnostics Launches C-Peptide Assay

May 21, 2018 | Calibrators, Pancreatic

Ortho Clinical Diagnostics has launched the Vitros Immunodiagnostic Products C-Peptide reagent pack and calibrators, which broadens the company’s menu of tests for all aspects of diabetes and other pancreatic disorders.

Category: Pancreatic

Pancreatic

Pancreatic

Pancreatic